91 related articles for article (PubMed ID: 2464824)
1. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion).
Tavassoli FA
Mod Pathol; 1988 Nov; 1(6):407-14. PubMed ID: 2464824
[TBL] [Abstract][Full Text] [Related]
2. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
3. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
4. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
Sangoi AR; McKenney JK; Dadras SS; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329
[TBL] [Abstract][Full Text] [Related]
5. Unusual features of serous neoplasms of low malignant potential during pregnancy.
Mooney J; Silva E; Tornos C; Gershenson D
Gynecol Oncol; 1997 Apr; 65(1):30-5. PubMed ID: 9103387
[TBL] [Abstract][Full Text] [Related]
6. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
7. Successful term pregnancy following conservative debulking surgery for a stage IIIA serous low-malignant-potential tumor of the ovary: a case report.
Miller DM; Ehlen TG; Saleh EA
Gynecol Oncol; 1997 Sep; 66(3):535-8. PubMed ID: 9299273
[TBL] [Abstract][Full Text] [Related]
8. [Serous and mucinous ovarian cystadenomas at the limit of malignancy].
Chenevart P; Gloor E
Schweiz Med Wochenschr; 1980 Apr; 110(14):531-9. PubMed ID: 7375903
[TBL] [Abstract][Full Text] [Related]
9. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
10. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
11. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
[TBL] [Abstract][Full Text] [Related]
12. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
13. The value of epithelial membrane antigen in the diagnosis of ovarian tumors.
Fujimoto I; Hirai Y; Hasumi K; Masubuchi K; Osamura Y
Acta Cytol; 1990; 34(4):549-54. PubMed ID: 1695804
[TBL] [Abstract][Full Text] [Related]
14. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
15. Management of epithelial ovarian tumors of low malignant potential.
Trimble CL; Trimble EL
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S52-61. PubMed ID: 7835812
[TBL] [Abstract][Full Text] [Related]
16. Transitional cell carcinoma of the endometrium and endometrial carcinoma with transitional cell differentiation.
Lininger RA; Ashfaq R; Albores-Saavedra J; Tavassoli FA
Cancer; 1997 May; 79(10):1933-43. PubMed ID: 9149020
[TBL] [Abstract][Full Text] [Related]
17. [A serous cystadenoma of the ovary of borderline malignancy with a fifteen-year history. A case report].
Nagata O; Aramaki S; Iino H; Ishikawa S; Yoshida H; Azekami M; Yamaguchi Y; Iwasa T; Matsukuma K; Iwata Y
Gan No Rinsho; 1990 Apr; 36(5):669-73. PubMed ID: 2325270
[TBL] [Abstract][Full Text] [Related]
18. [A case of malignant ovarian tumor complicated by pregnancy, from the standpoint of tumor marker and quality of life].
Okamoto M; Narushima M; Fukasawa H; Suzuki A; Hoshi S
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3287-90. PubMed ID: 2782921
[TBL] [Abstract][Full Text] [Related]
19. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
20. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
